PDL1 expression and its correlation with outcomes in non-metastatic triple-negative breast cancer (TNBC)
{{output}}
Purpose: Triple-negative breast cancer (TNBC) has a poor outcome compared to other subtypes, even in those with early disease. Immune checkpoint inhibitors (ICIs) have been approved in metastatic diseases and are being tested as ... ...